Evidence map›Paper›PMID 22586215›Full record

ArticleThe Journal of physiology2012

Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects.

Steen Larsen, Joachim Nielsen, Christina Neigaard Hansen, Lars Bo Nielsen, Flemming Wibrand, Nis Stride, Henrik Daa Schroder, Robert Boushel, Jørn Wulff Helge, Flemming Dela and 1 more

3 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 658 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
658citing papers in PubMed, 1 pooled it
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02255682 phase4completedstarted 2015, after this paper: background citation

Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being

Ran2015Enrolled35Registered outcomes5Posted comparisons0ConditionsCardiovascular Disease, Diabetes MellitusArmsQ10, simvastatin
Open the trial in the graph
NCT02796378 phase4unknown statusstarted 2016, after this paper: background citation

Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being

Ran2016Enrolled30Registered outcomes5Posted comparisons0ConditionsCardiovascular Disease, Diabetes MellitusArmsTraining+Simvastatin-placebo+Q10-placebo, Training+Simvastatin+Q10, Training+Simvastatin+Q10-placebo
Open the trial in the graph
NCT02250677 completednot on this mapstarted 2014, after this paper: background citation

LIFESTAT - Living With Statins, a Cross Sectional Study on the Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being

TypeobservationalSponsorUniversity of CopenhagenRan2014 to 2016Enrolled75ConditionsCardiovascular Disease, Diabetes Mellitus
3 · Its place in the literature

Who cites it

658 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,152 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Gut microbes · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

598 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Steen LarsenCenter for Healthy Aging-Department of Biomedical Sciences, Copenhagen University, Blegdamsvej 3b, DK-2200 Copenhagen, Denmark.
Joachim Nielsen
Christina Neigaard Hansen
Lars Bo Nielsen
Flemming Wibrand
Nis Stride
Henrik Daa Schroder
Robert Boushel
Jørn Wulff Helge
Flemming Dela
Martin Hey-Mogensen
University of Copenhagen · DKCopenhagen University Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle mitochondrial content varies extensively between human subjects. Biochemical measures of mitochondrial proteins, enzyme activities and lipids are often used as markers of mitochondrial content and muscle oxidative capacity (OXPHOS). The purpose of this study was to determine how closely associated these commonly used biochemical measures are to muscle mitochondrial content and OXPHOS. Sixteen young healthy male subjects were recruited for this study. Subjects completed a graded exercise test to determine maximal oxygen uptake (VO2peak) and muscle biopsies were obtained from the vastus lateralis. Mitochondrial content was determined using transmission electron microscopy imaging and OXPHOS was determined as the maximal coupled respiration in permeabilized fibres. Biomarkers of interest were citrate synthase (CS) activity, cardiolipin content, mitochondrial DNA content (mtDNA), complex I–V protein content, and complex I–IV activity. Spearman correlation coefficient tests and Lin's concordance tests were applied to assess the absolute and relative association between the markers and mitochondrial content or OXPHOS. Subjects had a large range of VO2peak (range 29.9–71.6ml min−1 kg−1) and mitochondrial content (4–15% of cell volume).Cardiolipin content showed the strongest association with mitochondrial content followed by CS and complex I activities. mtDNA was not related to mitochondrial content. Complex IV activity showed the strongest association with muscle oxidative capacity followed by complex II activity.We conclude that cardiolipin content, and CS and complex I activities are the biomarkers that exhibit the strongest association with mitochondrial content, while complex IV activity is strongly associated with OXPHOS capacity in human skeletal muscle.

Indexed as

Adenosine TriphosphatasesAdultBiomarkersCardiolipinsCarrier ProteinsCitrate (si)-SynthaseElectron Transport Complex IExercise TestHumansMaleMembrane ProteinsMicroscopy, Electron, TransmissionMitochondrial Proton-Translocating ATPasesMitochondria, MuscleMuscle Fibers, SkeletalOxidative PhosphorylationAdenosine TriphosphatasesBiomarkersCardiolipinsCarrier ProteinsCitrate (si)-SynthaseElectron Transport Complex IMembrane ProteinsMitochondrial Proton-Translocating ATPasesoligomycin sensitivity-conferring protein

Identifiers

PMID22586215
PMCPMC3459047
OpenAlexW2143588920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.